Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Familial Hypertrophic Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT01792960
4-2012-0869

Details and patient eligibility

About

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Enrollment

99 patients

Sex

All

Ages

13+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. left ventricular maximal wall thickness ≥ 15mm on echocardiography
  2. hypertrophic cardiomyopathy patients' relatives

Exclusion criteria

  1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease)
  2. who deny the study entrance, especially in patients' relatives

Trial design

99 participants in 1 patient group

familial hypertrophic cardiomyopathy
Description:
familial hypertrophic cardiomyopathy patients and their relatives

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems